EIFA WILLARD: Open Payments
NPI 1477293991 · CHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| ABBVIE INC. | 3 | $50 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Lilly USA, LLC | 2 | $33 |
| Exact Sciences Corporation | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| ABIOMED | 1 | $16 |
Products named: Ozempic, QULIPTA, MOUNJARO, Cologuard Collection Kit, VOQUEZNA, SHINGRIX, PAXLOVID, JARDIANCE.
Industry payments across VA — which companies pay providers there.
